Is the Combination of Pharmacokinetic and Pharmacodynamic Monitoring of Infliximab-Treated Patients the Way Forward?
Clinical Gastroenterology and Hepatology - United Kingdom
doi 10.1016/j.cgh.2020.02.029
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2020
Authors
Publisher
Elsevier BV